MD | Ticker Profile - Titan Protect

Pediatrix Medical Group, Inc.

Healthcare · Medical Care Facilities · NYQ

$22.61

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$1.8B

Total market value of the company

Trailing P/E

10.51

Reasonably valued

Forward P/E

9.18

Based on estimated future earnings — lower means cheaper

Rev Growth

+3.9%

Year-over-year revenue change

Profit Margin

9.0%

How much profit the company keeps from each dollar of revenue

ROE

20.9%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$23.50

+4% from current price — median analyst estimate

Recommendation

NONE

Consensus view from 6 analysts covering this stock

About Pediatrix Medical Group, Inc.

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

https://www.pediatrix.com

Country: United States Employees: 4,280 Industry: Medical Care Facilities

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

DISTRIBUTION

Smart money appears to be selling into strength — caution

Sharpe Ratio

1.338

Excellent risk-adjusted returns

Kelly Fraction

0.1165

Suggested allocation is meaningful — the edge justifies a position

Calmar Ratio

2.399

Returns exceed worst-case losses — strong risk profile

Annual Return

73.1%

Historical annualised return based on price data

Max Drawdown

-30.5%

Largest peak-to-trough decline — the worst it has been

HMM State

BEAR

Statistical model detects bearish conditions

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.71

Less volatile than the market — more defensive

52W High

$24.99

10% below the year high

52W Low

$11.84

91% above the year low

Avg Volume

840,180

Average daily shares traded — higher means easier to buy and sell

Short Ratio

4.2

Days it would take all short sellers to cover — higher means more crowded

Short % Float

6.0%

Moderate short interest

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$2.06

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

71.68

Heavy leverage — higher financial risk if revenues decline

Current Ratio

1.33

Adequate but worth monitoring

Quick Ratio

1.28

Like current ratio but excludes inventory — stricter test

Gross Margin

26.1%

Revenue left after cost of goods — higher means pricing power

Operating Margin

9.8%

Profit from core operations before interest and tax

Free Cash Flow

$164M

Positive — the business generates more cash than it spends

Revenue (TTM)

$1.9B

Total revenue over the last 12 months

Net Income

$174M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$27.00

Target Median

$23.50

Target Low

$19.00

Political Trading Activity

Congressional trading disclosures involving this instrument

Date	Politician	Party	Type	Amount
5 May2026	Josh Gottheimer	Democrat	buy	1K–15K
27 Apr2026	Josh Gottheimer	Democrat	buy	1K–15K
23 Apr2026	Josh Gottheimer	Democrat	buy	1K–15K

Source: Congressional disclosure filings. View all political trades at

Insider Intelligence

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go